John Markels

Currently holds a position at Sangamo Therapeutics, Inc.

3.3

3.3

Position	Company	Period
Independent Director	Sangamo Therapeutics, Inc.	Feb. 12, 2020 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Sangamo Therapeutics, Inc. (SGMOQ)

Transaction date 3 Jun 2022

Purchase

Price

472.48

Quantity 5,281 +48.4%

Value US$406,250

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2022-06-06	2022-06-03	Sangamo Therapeutics, Inc. (SGMOQ)	B Purchase	5,281 +48.4% 472.48 US$406,250	5,281 +48.4%	472.48	US$406,250